Inter-rater reliability of the Hamilton Depression Rating Scale as a diagnostic and outcome measure of depression in primary care

2008 ◽  
Vol 111 (2-3) ◽  
pp. 204-213 ◽  
Author(s):  
Richard Morriss ◽  
Morven Leese ◽  
Judy Chatwin ◽  
David Baldwin
2009 ◽  
Vol 51 (3) ◽  
pp. 191 ◽  
Author(s):  
J Thirthalli ◽  
TN Sathyaprabha ◽  
BN Gangadhar ◽  
MKrishna Prasad ◽  
K Udupa ◽  
...  

Rheumatology ◽  
2021 ◽  
Vol 60 (Supplement_1) ◽  
Author(s):  
Sebastian Moshtael ◽  
Sonia Khanom ◽  
Janet E McDonagh

Abstract Background/Aims  Fatigue has been reported by young people and professionals alike as a major challenge for people living with juvenile idiopathic arthritis (JIA) . It remains unclear as to how therapeutic interventions impacts on this major symptom. The aim of this review was to determine the current evidence for the effectiveness of therapeutic interventions, non- pharmacological and pharmacological, on improving fatigue in adolescents with JIA. Methods  Three electronic databases (MEDLINE, EMBASE, PsycINFO) were searched from 2000 to Feb 2020; in addition to manual searches. Articles were eligible for inclusion if they (i) were original research papers, (ii) had fatigue as a primary outcome measure (iii) included adolescents (10-25 years) and (iv) were available in the English language. Results  Of the 3,142 records identified, 31 underwent full text assessment and 4 studies were included in the qualitative synthesis including 2 from the Netherlands, 1 Germany, and 1 from Canada. The total number of participants across the 4 studies was 824. Three were randomised controlled trials of nonpharmacological interventions and one was a cohort study from a national drug registry including older adolescents JIA (mean: 19-years). Measurement tools included the Paediatric Quality of life multidimensional fatigue scale, (2 studies), the Checklist for Individual Strength CIS-20 (1 study), a numeric rating scale (1 study). In one study a visual analogue scale for energy level was also utilised. In 2 studies baseline prevalence of fatigue was reported as 60% and 76% respectively. Significant reduction in fatigue was observed in all three nonpharmacological studies. In the registry study, fatigue was noted to be prevalent in spite of the disease being in inactive or minimally active on biologic therapy. In 3 studies the relationship between health-related quality of life and fatigue was highlighted and showed a decreased quality of life in fatigued young people. Conclusion  Fatigue is a significant problem in JIA during adolescence and influences quality of life. Improvements in fatigue with non-pharmacological interventions have been reported. However, at present, data is insufficient to conclusively decide which treatment intervention is most efficacious in treating fatigue in young people with JIA. Fatigue should be considered as an important outcome measure for the management of JIA in future evaluations of interventions. Disclosure  S. Moshtael: None. S. Khanom: None. J.E. McDonagh: None.


2013 ◽  
Vol 5 (3) ◽  
pp. 141-146 ◽  
Author(s):  
Erita Istriana ◽  
Ade Kurnia ◽  
Annelies Weijers ◽  
Teddy Hidayat ◽  
Lucas Pinxten ◽  
...  

2004 ◽  
Vol 19 (2) ◽  
pp. 190-192 ◽  
Author(s):  
Elsdon Storey ◽  
Kate Tuck ◽  
Robert Hester ◽  
Andrew Hughes ◽  
Andrew Churchyard

2017 ◽  
Vol 13 (4) ◽  
pp. 305-311
Author(s):  
Tracy Hellem ◽  
Lindsay Scholl ◽  
Young-Hoon Sung ◽  
Hayden Ferguson ◽  
Erin McGlade ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document